162 research outputs found

    Nodes of the Gap Function and Anomalies in Thermodynamic Properties of Superfluid 3^3He

    Full text link
    Departures of thermodynamic properties of three-dimensional superfluid 3^3He from the predictions of BCS theory are analyzed. Attention is focused on deviations of the ratios Δ(T=0)/Tc\Delta(T=0)/T_c and [Cs(Tc)Cn(Tc)]/Cn(Tc)[C_s(T_c)-C_n(T_c)]/C_n(T_c) from their BCS values, where Δ(T=0)\Delta(T=0) is the pairing gap at zero temperature, TcT_c is the critical temperature, and CsC_s and CnC_n are the superfluid and normal specific heats. We attribute these deviations to the momentum dependence of the gap function Δ(p)\Delta(p), which becomes well pronounced when this function has a pair of nodes lying on either side of the Fermi surface. We demonstrate that such a situation arises if the P-wave pairing interaction V(p1,p2)V(p_1,p_2), evaluated at the Fermi surface, has a sign opposite to that anticipated in BCS theory. Taking account of the momentum structure of the gap function, we derive a closed relation between the two ratios that contains no adjustable parameters and agrees with the experimental data. Some important features of the effective pairing interaction are inferred from the analysis.Comment: 17 pages, 4 figure

    A terminal assessment of stages theory : introducing a dynamic states approach to entrepreneurship

    Get PDF
    Stages of Growth models were the most frequent theoretical approach to understanding entrepreneurial business growth from 1962 to 2006; they built on the growth imperative and developmental models of that time. An analysis of the universe of such models (N=104) published in the management literature shows no consensus on basic constructs of the approach, nor is there any empirical confirmations of stages theory. However, by changing two propositions of the stages models, a new dynamic states approach is derived. The dynamic states approach has far greater explanatory power than its precursor, and is compatible with leading edge research in entrepreneurship

    The Concise Guide to PHARMACOLOGY 2023/24: Ion channels.

    Get PDF
    The Concise Guide to PHARMACOLOGY 2023/24 is the sixth in this series of biennial publications. The Concise Guide provides concise overviews, mostly in tabular format, of the key properties of approximately 1800 drug targets, and over 6000 interactions with about 3900 ligands. There is an emphasis on selective pharmacology (where available), plus links to the open access knowledgebase source of drug targets and their ligands (https://www.guidetopharmacology.org/), which provides more detailed views of target and ligand properties. Although the Concise Guide constitutes almost 500 pages, the material presented is substantially reduced compared to information and links presented on the website. It provides a permanent, citable, point-in-time record that will survive database updates. The full contents of this section can be found at http://onlinelibrary.wiley.com/doi/10.1111/bph.16178. Ion channels are one of the six major pharmacological targets into which the Guide is divided, with the others being: G protein-coupled receptors, nuclear hormone receptors, catalytic receptors, enzymes and transporters. These are presented with nomenclature guidance and summary information on the best available pharmacological tools, alongside key references and suggestions for further reading. The landscape format of the Concise Guide is designed to facilitate comparison of related targets from material contemporary to mid-2023, and supersedes data presented in the 2021/22, 2019/20, 2017/18, 2015/16 and 2013/14 Concise Guides and previous Guides to Receptors and Channels. It is produced in close conjunction with the Nomenclature and Standards Committee of the International Union of Basic and Clinical Pharmacology (NC-IUPHAR), therefore, providing official IUPHAR classification and nomenclature for human drug targets, where appropriate

    Applied aspects of pineapple flowering

    Full text link

    Iam hiQ—a novel pair of accuracy indices for imputed genotypes

    Get PDF
    Background Imputation of untyped markers is a standard tool in genome-wide association studies to close the gap between directly genotyped and other known DNA variants. However, high accuracy with which genotypes are imputed is fundamental. Several accuracy measures have been proposed and some are implemented in imputation software, unfortunately diversely across platforms. In the present paper, we introduce Iam hiQ, an independent pair of accuracy measures that can be applied to dosage files, the output of all imputation software. Iam (imputation accuracy measure) quantifies the average amount of individual-specific versus population-specific genotype information in a linear manner. hiQ (heterogeneity in quantities of dosages) addresses the inter-individual heterogeneity between dosages of a marker across the sample at hand. Results Applying both measures to a large case–control sample of the International Lung Cancer Consortium (ILCCO), comprising 27,065 individuals, we found meaningful thresholds for Iam and hiQ suitable to classify markers of poor accuracy. We demonstrate how Manhattan-like plots and moving averages of Iam and hiQ can be useful to identify regions enriched with less accurate imputed markers, whereas these regions would by missed when applying the accuracy measure info (implemented in IMPUTE2). Conclusion We recommend using Iam hiQ additional to other accuracy scores for variant filtering before stepping into the analysis of imputed GWAS data
    corecore